Determining ProGRP and isoforms in lung and thyroid cancer patient samples: Comparing an MS method with a routine clinical immunoassay

Analytical and Bioanalytical Chemistry

Volumn 406, Issue 11, 2014, Pages 2733-2738

  Torsetnes, Silje Bøen ^a   Broughton, Marianne Nordlund ^b   Paus, Elisabeth ^b   Halvorsen, Trine Grønhaug ^a   Reubsaet, Léon ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Biomarker; Bottom up; Immunoassay; Immunocapture; LC SRM MS; Progastrin releasing peptide; Signature peptide; Targeted protein analysis

Indexed keywords

BIOLOGICAL ORGANS; BIOMARKERS; DIAGNOSIS; IMMUNOLOGY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PEPTIDES; TUMORS;

BOTTOM UP; IMMUNOASSAY; IMMUNOCAPTURE; LC-SRM-MS; TARGETED PROTEINS;

DISEASES;

PEPTIDE FRAGMENT; PRO-GASTRIN-RELEASING PEPTIDE (31-98); RECOMBINANT PROTEIN; TUMOR MARKER;

BLOOD; COMPARATIVE STUDY; DIAGNOSTIC USE; HUMAN; IMMUNOASSAY; LUNG NEOPLASMS; MASS SPECTROMETRY; PROCEDURES; THYROID NEOPLASMS;

HUMANS; IMMUNOASSAY; LUNG NEOPLASMS; MASS SPECTROMETRY; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84898040760     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-014-7634-x     Document Type: Article

References (10)

1. Niho S, Nishiwaki Y, Goto K, Ohmatsu H, Matsumoto T, Hojo F, Ohe Y, Kakinuma R, Kodama T (2000) Significance of serum pro-gastrin-releasing peptide as a predictor of relapse of small cell lung cancer: comparative evaluation with neuron-specific enolase and carcinoembryonic antigen. Lung Cancer 27(3):159-167
2. Torsetnes SB, Nordlund MS, Paus E, Halvorsen TG, Reubsaet L (2013) Digging deeper into the field of the small cell lung cancer tumor marker ProGRP: a method for differentiation of its isoforms. J Proteome Res 12(1):412-420. doi: 10.1021/pr300751j
3. Aoyagi K, Miyake Y, Urakami K, Kashiwakuma T, Hasegawa A, Kodama T, Yamaguchi K (1995) Enzyme-immunoassay of immunoreactive progastrin-releasing peptide(31-98) as tumor-marker for small-cell lung-carcinoma - development and evaluation. Clin Chem 41(4):537-543
4. Nordlund MS, Warren DJ, Nustad K, Bjerner J, Paus E (2008) automated time-resolved immunofluorometric assay for progastrin-releasing peptide. Clin Chem 54(5):919-922. doi: 10.1373/clinchem.2007.101436
5. Nordlund MS, Stieber P, Brustugun OT, Warren DJ, Paus E (2012) Characteristics and clinical validity of two immunoassays for ProGRP. Tumour Biol 33(4):1105-1113. doi: 10.1007/s13277-012-0351-1
6. Nordlund MS, Bjerner J, Warren DJ, Nustad K, Paus E (2008) Progastrin-releasing peptide: stability in plasma/serum and upper reference limit. Tumour Biol 29(3):204-210. doi: 10.1159/000148188
7. Nordlund MS, Fermer C, Nilsson O, Warren DJ, Paus E (2007) Production and characterization of monoclonal antibodies for immunoassay of the lung cancer marker proGRP. Tumour Biol 28(2):100-110
8. Paus E, Nustad K (1989) Immunoradiometric assay for alpha-gamma-enolase and gamma-gamma-enolase (neuron-specific enolase), with use of monoclonal antibodies and magnetizable polymer particles. Clin Chem 35(10):2034-2038
9. Guideline on bioanalytical method validation (2011) EMEA/CHMP/EWP/192217/ 2009. EMA/CHMP: 1-22
10. Spindel ER, Zilberberg MD, Chin WW (1987) Analysis of the gene and multiple messenger ribonucleic acids (mRNAs) encoding human gastrin-releasing peptide: alternate RNA splicing occurs in neural and endocrine tissue. Mol Endocrinol 1(3):224-232. doi: 10.1210/mend-1-3-224